IP Library Granted Patent US 7,687,616
Granted Patent B1
US 7,687,616 · App. 10/709,577 · Granted Mar 30, 2010

Small molecules modulating activity of micro RNA oligonucleotides and micro RNA targets and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,687,616
App. No.
10/709,577
Granted
Mar 30, 2010
Kind
B1
Abstract

The present invention describes a novel approach whereby small molecules may be used to modulate activity of microRNA and GAM oligonucleotides. This mode of therapy allows inter alia up regulation of a disease-related target gene of novel GAM oligonucleotides of the present invention, by countering the activity of a GAM oligonucleotides which naturally inhibits expression of that target gene. Nucleic acid molecules are provided respectively encoding 122,764 GAM oligonucleotides and their respective precursors, and 18602 GR polynucleotides, as are vectors and probes both comprising the nucleic acid molecules, and methods and systems for detecting GAM oligonucleotides and GR polynucleotides and specific functions and utilities thereof, for detecting expression of GAM oligonucleotides and GR polynucleotides, and for selectively enhancing and selectively inhibiting translation of the respective target genes thereof.

Claims (11)

1. An isolated nucleic acid, wherein the nucleic acid consists of a sequence selected from the group consisting of:

(a) SEQ ID NO: 7002375;

(b) an RNA encoded by (a);

(c) a sequence at least 80% identical to (a) or (b) wherein the sequence is 19-24 nucleotides; and

(d) the complement of any one of (a)-(c), wherein the complement is identical in length to (a).

2. An isolated nucleic acid, wherein the nucleic acid consists of a sequence selected from the group consisting of:

(a) SEQ ID NO:6816665;

(b) an RNA encoded by (a);

(c) the complement of (a) or (b), wherein the complement is identical in length to (a).

3. A vector comprising a human insert, wherein the human insert consists of the nucleic acid of claim 1 or claim 2 , and wherein the vector comprises no insert other than the nucleic acid of claim 1 or claim 2 .

4. A probe comprising a human insert, wherein the human insert consists of the nucleic acid of claim 1 or claim 2 , and wherein the probe comprises no insert other than the nucleic acid of claim 1 or claim 2 .

Assignments (2)
SECURITY INTEREST Recorded Dec 15, 2017
From: ROSETTA GENOMICS INC.; ROSETTA GENOMICS LTD; MINUET DIAGNOSTICS, INC.; CYNOGEN INC.
To: GENOPTIX, INC.
Reel/Frame 044899/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2004
From: BENTWICH, ITZHAK; AVNIEL, AMIR
To: ROSETTA GEMONICS LTD
Reel/Frame 014611/0671 →